abbv  230728c00155000

Sold all ABBV $155 Calls

This member connected a brokerage account and is sharing trades and portfolio performance with the community. 

Public Portfolio

Zachary Rapp

Bought ABBV $155 Calls

abbv  230818c00145000

Sold 33% of ABBV $145 Calls

kxian

Sold 25% of ABBV $145 Calls

Sold 20% of ABBV $145 Calls

Bought 25% more ABBV $145 Calls

Bought 33% more ABBV $145 Calls

Bought 100% more ABBV $145 Calls

abbv  230818c00140000

Sold 50% of ABBV $140 Calls

abbv  230707c00140000

Sold all ABBV $140 Calls

Bought 33% more ABBV $140 Calls

Bought 200% more ABBV $140 Calls

Sold 67% of ABBV $145 Calls

abbv  230818c00150000

Sold 50% of ABBV $150 Calls

Bought ABBV $140 Calls

abbv  230630c00140000

Bought 67% more ABBV $140 Calls

Bought 20% more ABBV $150 Calls

AbbVie Inc. is a pharmaceutical company headquartered in North Chicago, Illinois. It is ranked 6th on the list of largest biomedical companies by revenue. Their primary product is Humira (adalimumab) ($21 billion in 2022 revenues, 37% of total), administer

ABBVIE INC.

Bought 1% more ABBV

Dennis Shah

Sold short 6% more ABBV

Jonah Grant

Sold short 7% more ABBV

Sold short 8% more ABBV

Sold short 9% more ABBV

Sold short 10% more ABBV

Bought to close 9% ABBV

Bought to close 8% ABBV

Bought to close 7% ABBV

Bought <1% more ABBV

This member is verified by the Commonstock team based on their contributions to the Commonstock community. 